Shree Ram Proteins Ltd. Corrigendum for 17th AGM Notice and Annual Report 2024-25
Shree Ram Proteins Limited has issued a corrigendum and addendum for its 17th Annual General Meeting (AGM) notice and Annual Report 2024-25. The AGM is scheduled for March 5, 2026. The corrigendum clarifies director appointment details, and the addendum includes the Secretarial Audit Report.
This announcement is a procedural clarification for an upcoming AGM and does not involve any new financial outcomes or strategic changes that would significantly impact the company's operations or stock.
The announcement is a corrigendum and addendum to a previous filing, providing clarifications and additional information. It does not contain any new financial results or significant business developments that would warrant a positive or negative sentiment.
Shree Ram Proteins Limited has issued a corrigendum and addendum to the notice of its 17th Annual General Meeting (AGM) and the Annual Report for the financial year 2024-25. The AGM is scheduled to be held on Thursday, March 05, 2026, at 2:00 p.m. through Video Conferencing / Other Audio Visual Means.
The corrigendum clarifies details regarding the appointment of directors. Specifically, Item No. 2 in the AGM notice, which pertains to the appointment of a director in place of Mr. Ravindra Kumar Singh who retires by rotation, should be read as concerning the appointment of a director in place of Mr. Piyush Vasoya, who also retires by rotation and offers himself for reappointment.
Additionally, an addendum to the Annual Report 2024-25 has been provided, including the Secretarial Audit Report for FY 2024-25, which was not included in the earlier intimation of the annual report. This corrigendum and addendum form an integral part of the Notice of the 17th AGM and the Annual Report 2024-25, and are available on the company's website and the NSE website.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.